David Leyssene
Impact in
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 2
- Clostridium difficile and Clostridium perfringens research 2
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- Julien Delmas (3 shared papers)Richard Bonnet (3 shared papers)Damien Dubois (2 shared papers)Markus Kostrzewa (1 shared paper)Régine Talòn (1 shared paper)Frédéric Robin (2 shared papers)Catherine Birck (1 shared paper)Emilie Vazeille (1 shared paper)
In The Last Decade
David Leyssene
10 papers receiving 293 citations
Peers
Comparison fields: 5 of 48
- Clinical Biochemistry 148
- Molecular Medicine 62
- Infectious Diseases 114
- Endocrinology 28
- Epidemiology 101
Countries citing papers authored by David Leyssene
This map shows the geographic impact of David Leyssene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Leyssene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Leyssene more than expected).
Fields of papers citing papers by David Leyssene
This network shows the impact of papers produced by David Leyssene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Leyssene. The network helps show where David Leyssene may publish in the future.
Co-authors
The 25 scholars most cited alongside David Leyssene, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 172 | |
| 2 | 2010 | 46 | |
| 3 | 2011 | 24 | |
| 4 | 2019 | 23 | |
| 5 | 2016 | 18 | |
| 6 | 2011 | 8 | |
| 7 | 2017 | 3 | |
| 8 | 2021 | 3 | |
| 9 | 2018 | 2 | |
| 10 | 2012 | 1 | |
| 11 | 2012 | 0 |
About David Leyssene
David Leyssene is a scholar working on Infectious Diseases, Molecular Biology, Pharmacology, Epidemiology and Clinical Biochemistry, having authored 11 papers that have together received 300 indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Antibiotic Resistance in Bacteria (2 papers), Streptococcal Infections and Treatments (1 paper), Cancer therapeutics and mechanisms (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Clinical Biochemistry (148 citations), Molecular Medicine (62 citations), Infectious Diseases (114 citations), Endocrinology (28 citations) and Epidemiology (101 citations). David Leyssene has collaborated with scholars based in France, Germany and Greece. Frequent co-authors include Julien Delmas, Richard Bonnet, Damien Dubois, Markus Kostrzewa, Régine Talòn, Frédéric Robin, Catherine Birck, Emilie Vazeille, Jean‐Pierre Flandrois and Brigitte Lamy. Their work appears in journals such as Annals of Physical and Rehabilitation Medicine, Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.